IRMA-International.org: Creator of Knowledge
Information Resources Management Association
Advancing the Concepts & Practices of Information Resources Management in Modern Organizations

High-Risk Patients for Gynaecological Cancer: What Is the Optimal Clinical Approach?

High-Risk Patients for Gynaecological Cancer: What Is the Optimal Clinical Approach?
View Sample PDF
Author(s): Evangelia Mareti (2nd Department of Obstetrics and Gynaecology, Aristotle University of Thessaloniki, Greece), Chrysoula Margioula-Siarkou (2nd Department of Obstetrics and Gynaecology, Aristotle University of Thessaloniki, Greece), George Mavromatidis (2nd Department of Obstetrics and Gynaecology, Aristotle University of Thessaloniki, Greece)and Frederic Guyon (Gynaecologic Oncology Unit, Institut Bergonie, Bordeaux, France)
Copyright: 2021
Pages: 15
Source title: Handbook of Research on Oncological and Endoscopical Dilemmas in Modern Gynecological Clinical Practice
Source Author(s)/Editor(s): Konstantinos Dinas (2nd Department of Obstetrics and Gynaecology, Aristotle University of Thessaloniki, Greece), Stamatios Petousis (2nd Department of Obstetrics and Gynaecology, Aristotle University of Thessaloniki, Greece), Matthias Kalder (Department of Obstetrics and Gynaecology, Philipps-University of Marburg, Germany)and George Mavromatidis (2nd Department of Obstetrics and Gynaecology, Aristotle University of Thessaloniki, Greece)
DOI: 10.4018/978-1-7998-4213-2.ch004

Purchase

View High-Risk Patients for Gynaecological Cancer: What Is the Optimal Clinical Approach? on the publisher's website for pricing and purchasing information.

Abstract

Patients at high risk for gynaecological cancer consist of a specific category of patients in which clinical, imaging, and laboratory surveillance may actually be differentiated compared with low-risk patients. The chapter aims to summarize current evidence and recommendations regarding optimal clinical management of high-risk patients for all forms of gynaecological cancer, namely cervical cancer, endometrial cancer, ovarian cancer, and breast cancer. Furthermore, it aims to approach critically the need for estimating cost-benefit of all preventative modalities along with discrepancies in existing guidelines.

Related Content

Genevieve Z. Steiner-Lim, Madilyn Coles, Kayla Jaye, Najwa-Joelle Metri, Ali S. Butt, Katerina Christofides, Jackson McPartland, Zainab Al-Modhefer, Diana Karamacoska, Ethan Russo, Tim Karl. © 2023. 47 pages.
Mohd Kashif, Mohammad Waseem, Poornima D. Vijendra, Ashok Kumar Pandurangan. © 2023. 28 pages.
Courtney R. Acker, Rana R. Zeine. © 2023. 27 pages.
Mahesh Pattabhiramaiah, Shanthala Mallikarjunaiah. © 2023. 16 pages.
Dhairavi Shah, Dhaara Shah, Yara Mohamed, Danna Rosas, Alyssa Moffitt, Theresa Hearn Haynes, Francis Cortes, Taunjah Bell Neasman, Phani kumar Kathari, Ana Villagran, Rana R. Zeine. © 2023. 28 pages.
Mohammad Uzair, Hammad Qaiser, Muhammad Arshad, Aneesa Zafar, Shahid Bashir. © 2023. 23 pages.
Akila Muthuramalingam, Ashok Kumar Pandurangan, Subhamoy Banerjee. © 2023. 17 pages.
Body Bottom